Schonfeld Strategic Advisors LLC Savara Inc Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Savara Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 646,668 shares of SVRA stock, worth $2.24 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
646,668
Previous 177,100
265.14%
Holding current value
$2.24 Million
Previous $881,000
195.8%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding SVRA
# of Institutions
147Shares Held
147MCall Options Held
280KPut Options Held
798K-
Nea Management Company, LLC Timonium, MD24.5MShares$84.7 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$50.4 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$42.8 Million7.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$28.2 Million1.94% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$27.8 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $395M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.